Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Health Affairs (Project Hope)|November 6, 2007
Toward a rational, value-based drug benefit for MedicareRuth Lopert, Marilyn MoonIssue Brief (Commonwealth Fund)|July 31, 2009
Evidence-based decision-making within Australia's pharmaceutical benefits schemeRuth LopertThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 16, 2013
The high price of "free" trade: U.S. trade agreements and access to medicinesRuth Lopert, Deborah GleesonZeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 3, 2014
Revolution then evolution: the advance of health economic evaluation in AustraliaRuth Lopert, Rosalie VineyThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and AustraliaRuth Lopert, Sara RosenbaumHealth Affairs (Project Hope)|April 10, 2013
Australia's 'fourth hurdle' drug review comparing costs and benefits holds lessons for the United StatesRuth Lopert, Adam G ElshaugOpen Medicine : a Peer-Reviewed, Independent, Open-Access Journal|May 24, 2011
Toward a definition of pharmaceutical innovationSteven Morgan, Ruth Lopert, Devon GreysonHealth Policy (Amsterdam, Netherlands)|August 20, 2013
Applying rapid 'de-facto' HTA in resource-limited settings: experience from RomaniaRuth Lopert, Francis Ruiz, Kalipso ChalkidouHealth Policy (Amsterdam, Netherlands)|September 3, 2013
How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New ZealandDeborah Gleeson, Ruth Lopert, Papaarangi ReidAsia-Pacific Journal of Public Health|December 7, 2016
The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to MedicinesBelinda Townsend, Deborah Gleeson, Ruth LopertPageof 5